ArticleClinical kidney journal2025
Kidney Failure Risk Equation performance according to the etiology of chronic kidney disease in the CKD-CAREMEAU cohort.
Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Systematic Evaluation of Plasma and Urine Metabolites to Predict the Risk of Adverse Kidney-related Outcomes in Chronic Kidney Disease: The GCKD Study∗.Kidney medicine · 2026Article
- Planning of kidney replacement therapy in advanced CKD using the KFRE formula in a Spanish multicenter cohort.Clinical kidney journal · 2026Article
- Which equation and which biomarker should be used in the Kidney Failure Risk Equation? A comparative analysis in the CKD-REIN cohort.Clinical kidney journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Kidney Failure Risk Equation (KFRE) is a prognostic score for predicting kidney replacement therapy (KRT) at 5 years in patients with chronic kidney disease (CKD). Some studies show that the score performs poorly for certain etiologies of CKD but not all have been evaluated. The aim of this study was to evaluate the performance of the KFRE score according to the etiology of the CKD. Methods: The CKD-CAREMEAU cohort, which included all patients who consulted a nephrologist for CKD between 2008 and 2017, was used. Patients were monitored for 5 years and the observed event was KRT, completed by the French REIN registry (Reseau Epidemiologique et Information en Néphrologie). Performance was evaluated by calibration (individual approach) and discrimination (populational approach), using observed vs predicted risk curves and the area under curve, respectively, according to each etiology. Results: A total of 3191 patients were included in the study, median age 71 (interquartile range 61-80) years, 1921 (60%) of whom were men, and the median estimated glomerular filtration rate was 41 (28-80) mL/min/1.73 m². The main etiologies of CKD were vascular; 1164 patients (37%), diabetic; 667 (21%), glomerular; 512 (16%), tubulointerstitial; 459 (14%), polycystic; 121 (4%) and unclassified; and 268(8%). Discrimination was satisfactory for all etiologies, but calibration was unsatisfactory for polycystic, tubulointerstitial and unclassified (multiple or unknown) etiologies, without correlation with age. Conclusions: Predictive performance of the KFRE score at 5 years varies according to the etiology of CKD, without impact on discrimination, but with a significant impact on calibration, and poor performance for polycystic, tubulointerstitial and multiple/unknown etiologies. These limitations should be known in order to develop new prognostic tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.